Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532

Logo Tollys


Confirmation by MATWIN’s panel of scientific and industry experts of therapeutic potential of TL-532 major boost for Tollys, supports moving flagship product towards clinical phase


A new dimension in immuno-oncology


60F avenue Rockefeller
69008 Lyon, FRANCE

Contact us